Radiation treatment of hemato-oncological patients in times of the COVID-19 pandemic
ConclusionRT for hemato-oncological patients receives high-priority and should be maintained even in later stages of the pandemic. Hypofractionation and shortened treatment schedules are feasible options for well-defined constellations, but have to be discussed in the clinical context.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Cancer & Oncology | Coronavirus | COVID-19 | Emergency Medicine | Germany Health | Hodgkin's Disease | Leukemia | Lymphoma | Myeloma | Orthopaedics | Palliative | Pandemics | Radiation Therapy | Study